Subscribe to Newsletter

Business Practice

Discovery & Development Contract Development Services

Renaissance Man

| Cornell Stamoran

Sitting Down With... Cornell Stamoran, Vice President of Corporate Strategy, Catalent Pharma Solutions, USA.

Business & Regulation Business Practice

They Shoot Horses, Don’t They?

| Victoria F. Samanidou

Is age related to research productivity – and, if so, to what extent?

Business & Regulation Business Practice

Business-in-Brief

| William Aryitey

Record generic approvals, a joint opioid investigation... What’s new for pharma in business?

Manufacture Business Practice

Saving Lives by Design

| Stephanie Vine

An exhibition in London explores the relationship between graphic design and health.

Business & Regulation Business Practice

IP Deal or No Deal?

| William Aryitey

The future status of pharma intellectual property in the UK depends on the outcome of Brexit.

Manufacture Standards & Regulation

Serialization Blind Spots

| Pavel Lotkov

Serialization is far from simple, and many companies overlook key aspects

Discovery & Development Biosimilars

Champion of Generics

| Abhijit Mukherjee

Sitting Down With… Abhijit Mukherjee, COO of Dr. Reddy's Laboratories, India

Business & Regulation Business Practice

Business-in-Brief

| James Strachan

Keeping close ties, locking-up loopholes, and calculating costs… What's new for pharma in business?

Discovery & Development Business Practice

Leaving on a Jet Plane

| Stephanie Vine

One of the biggest pharma trade shows in Europe kicks off at the end of October

Manufacture Business Practice

Here’s to Shared Successes!

| Stephanie Vine

This issue marks The Medicine Maker's third birthday!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register